Form 4: Atara Biotherapeutics Director Buys Shares
Insider Transaction (Form 4)
Brian N Cherry, a Director of Atara Biotherapeutics, Inc., purchased 104,166 shares of common stock on September 4, 2026 for $9.60 per share.
Summary
- Open-market purchase: acquired 104,166 Common Stock at $9.60 ($999,994) on September 4, 2026; holds 166,486 after (Direct).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $999,994, committing personal capital to the stock.
Insider Transactions
Brian N Cherry — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Open-market purchase | Common Stock | 104,166 | $10 | $1000.0K | 166,486 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Open-market purchase (104,166 shares) |
Keywords
insider transaction, Form 4, ATRA, Atara Biotherapeutics, Inc., bullish, Brian N Cherry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.